Litigation Details for ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED v. SUN PHARMACEUTICAL INDUSTRIES LTD. (D.N.J. 2020)
✉ Email this page to a colleague
ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED v. SUN PHARMACEUTICAL INDUSTRIES LTD. (D.N.J. 2020)
| Docket | ⤷ Subscribe | Date Filed | 2020-08-07 |
| Court | District Court, D. New Jersey | Date Terminated | 2021-03-18 |
| Cause | 15:1126 Patent Infringement | Assigned To | Susan Davis Wigenton |
| Jury Demand | None | Referred To | Leda Dunn Wettre |
| Patents | 9,089,492 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED v. SUN PHARMACEUTICAL INDUSTRIES LTD.
The small molecule drug covered by the patent cited in this case is ⤷ Subscribe .
Details for ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED v. SUN PHARMACEUTICAL INDUSTRIES LTD. (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-08-07 | 1 | Complaint | Page 2 of 16 PageID: 2 States Patent No. 9,089,492 (“the ’492 Patent”). Plaintiffs seek injunctive relief… 1. This action for patent infringement, brought pursuant to the patent laws of the United States…14. This civil action for patent infringement arises under the patent laws of the United States, including…the United States Patent and Trademark Office duly and legally issued the ’492 Patent, titled “Pharmaceutical… the ’492 Patent, having acquired the entire right, title, and interest in the ’492 Patent from Warner | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
